-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, ICkSlRR7axEHwaSirTQX1tdc96WLi/PJHTdIy3SYiW4v5gjAnbCLeiodX3koA57T Nz/Liq/aOfzcxRX3Br8bNA== 0000849043-04-000111.txt : 20041216 0000849043-04-000111.hdr.sgml : 20041216 20041216144307 ACCESSION NUMBER: 0000849043-04-000111 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20041215 FILED AS OF DATE: 20041216 DATE AS OF CHANGE: 20041216 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEUROGEN CORP CENTRAL INDEX KEY: 0000849043 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 222845714 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 BUSINESS PHONE: 2034888201 MAIL ADDRESS: STREET 1: 35 NORTHEAST INDUSTRIAL RD CITY: BRANFORD STATE: CT ZIP: 06405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: CARLUCCI FRANK C CENTRAL INDEX KEY: 0001026039 STATE OF INCORPORATION: KY FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-18311 FILM NUMBER: 041207799 BUSINESS ADDRESS: STREET 1: THE CARLYLE GROUP STREET 2: 1001 PENNSYLVANIA AVENUE N W CITY: WASHINGTON STATE: DC ZIP: 20004-2505 BUSINESS PHONE: 3146944492 MAIL ADDRESS: STREET 1: CARLYLE GROUP STREET 2: 1001 PENNSYLVANIA AVENUE N W CITY: WASHINGTON STATE: DC ZIP: 20004-2502 4 1 edgar.xml PRIMARY DOCUMENT X0202 4 2004-12-15 0000849043 NEUROGEN CORP NRGN 0001026039 CARLUCCI FRANK C 35 NE INDUSTRIAL RD. BRANFORD CT 06405 1 0 0 0 Common Stock 2004-12-15 4 M 0 5000 9.14 A 131325 D Stock Options (Right to Buy) 9.14 2004-12-15 4 A 0 2500 A 2014-12-15 Common Stock 2500 2500 D Stock Options (Right to Buy) 6.50 2004-12-15 4 M 0 5000 0 D 2004-12-30 Common Stock 5000 0 D Pursuant to the Neurogen Corporation 2000 Non-Employee Directors Stock Option Program, the options will vest in three (3) monthly installments on the last day of each month, beginning the last day of the month in which such option was granted. The option was granted under an employee stock option plan, for no consideration. The option vested one-thirty-sixth (1/36) per month, beginning with the last day of the month in which such options were granted, which was December 30, 1994. Stephen Davis, Attorney-in-fact 2004-12-16 EX-24 2 carlucci.htm POWER OF ATTORNEY

                  POWER OF ATTORNEY









 The undersigned hereby appoints Stephen R. Davis, EVP

and Chief Business Officer of Neurogen Corporation, his or her

attorney-in-fact and agent in any and all capacities to execute

for and on his or her behalf filings with the Securities and

Exchange Commission on Forms 3, 4 or 5 pursuant to Section 16

of the Securities and Exchange Act of 1934, as amended, to the

extent that such filings relate to the undersigned's status as

a director or officer of Neurogen Corporation.  The undersigned

further appoints Stephen R. Davis his or her attorneyin fact

and agent to execute any and all amendments to such filings as

such attorney-in-fact and agent deems appropriate.  The

undersigned hereby grants to such attorney-in-fact and agent

full power and authority to do and perform each and every act

necessary or desirable as the undersigned could do in person,

hereby ratifying and confirming all that such attorney in fact

and agent may lawfully do or has done by virtue hereof.



This Power of Attorney shall become effective as of February 12, 2001.





/s/ FRANK C. CARLUCCI

_____________________________

Frank C. Carlucci

-----END PRIVACY-ENHANCED MESSAGE-----